This is the second such pilot involving Walmart to be announced in as many weeks, and it will add yet another flavor of distributed ledger technology (DLT) to the drug-tracking use case. The new drug pilot will build on the work Big Blue has already done with Walmart, said Mark Treshock, IBM’s blockchain solutions Leader for healthcare and life sciences.
Read in Full
CoinMarkets is an automated news aggregation service. All copyrights belong to their respective owners. Images and text owned by copyright holders are used in reference to and promotion of those respective parties.
“The project with KPMG Merck and Walmart, even though it’s a pilot, is going to be leveraging the production blockchain platforms that we have developed for Walmart with FoodTrust and also with Maersk in TradeLens,” he said, adding:
“So it’s not just a science experiment.” Competing chains
On the subject of Walmart participating in a Hyperledger pilot with IBM and at the same time working with Mediledger’s ethereum-based blockchain, Eric Garvin, co-lead at MediLedger, said it was not surprising since Walmart and IBM collaborate on FoodTrust.